Live
- Scientists develop flexible near-infrared devices for wearable sensors
- Transforming education for the workforce of tomorrow
- Despite global odds, GDP growth at 6-7% good for India
- IIFL Home Fin to raise Rs 500 cr
- Sensex, Nifty drift lower on profit booking
- Jagan treated cadres as ‘subordinates’, alleges Grandhi
- Mpower’s survey on edu loans
- IIP growth falls to 3.5% in Oct
- Easing food prices lower retail inflation to 5.48% in November
- Space allocation for packaging units at MSME parks on anvil
Injection bottles get fungus infection
Following the detection of fungus in Pralidoxime injection bottles produced by the Himalaya Company in MGM Hospital, here, causing a sensation as the Drug Control Administration (DCA) officials have issued orders that it should not be used across the State, even as Superintendent Dr Karunakar declared that there was not stock of the injection. However, DCA officials, who became alert, seized 45 in
Warangal: Following the detection of fungus in Pralidoxime injection bottles produced by the Himalaya Company in MGM Hospital, here, causing a sensation as the Drug Control Administration (DCA) officials have issued orders that it should not be used across the State, even as Superintendent Dr Karunakar declared that there was not stock of the injection. However, DCA officials, who became alert, seized 45 injection bottles during the last two days.
The fungus in the injection bottle was detected on Sunday night when it was being administered to a patient. The incident exposed the negligent attitude of MGM officials posing a threat to the lives of patients. This injection is given to provide relief to those who consume insecticide.
Highlights:
- Officials seize 45 bottles during last two days
- Injection containing fungus purchased locally
- Doctors try to bluff injection was not available in hospital
- Superintendent Dr Karunakar orders check of entire stock in pharmacy
- Injection should not be not used across State: DCA
- Officials shift stocks to lab after detecting fungus
- Patients demand comprehensive inquiry into local purchase of medicines by hospital staff
The officials again conducted searches on Monday as staff of the pharmacy was not available the previous night. The staff reportedly troubled the officials for two hours to provide information on Monday.
However, when Drug Control Deputy Director Surendranath Sai joined the search, the staff displayed the injection stocks. The DCA officials said they were shifting the stocks to a lab after detecting the fungus and ordered that the injection be not used across the State until the lab report was received.
The DCA officials, who identified that the injection containing the fungus, said it was purchased locally despite being available in the Central Drug Store. They said that the fungus could cause fatalities. Doctors tried to bluff that the injection was not available in the hospital.
The superintendent told The Hans India that orders have been issue to check the entire stock in the pharmacy. He stated that available stock was being sent for tests. Some patients told THI that a comprehensive inquiry into the local purchase of medicines by the hospital staff could reveal shortcomings.
